Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection

ClinicalTrials.gov ID: NCT00195351

Public ClinicalTrials.gov record NCT00195351. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 1:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Open-Label, Randomized Comparative Study of Tigecycline vs Ceftriaxone Sodium Plus Metronidazole for the Treatment of Hospitalized Subjects With Complicated Intra-abdominal Infection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase 3b/4 randomized, open-label, comparative, multicenter study of the safety and efficacy of tigecycline to ceftriaxone sodium plus metronidazole in hospitalized subjects with cIAI (Complicated Intra-Abdominal Infection). Subjects with clinical signs and symptoms of cIAI will be included for enrollment. Subjects will be stratified at randomization for Acute Physiologic and Chronic Health Evaluation scale (APACHE II) score \< 10 and \> 10. Subjects will be followed for efficacy through the test-of-cure assessment. Safety evaluations will occur through the treatment and post-treatment periods and continue through resolution or stability of the adverse event(s).

Study identification

NCT ID
NCT00195351
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Enrollment
467 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2005 (Type not available)
Primary completion
Feb 2008 (Actual)
Completion
Feb 2008 (Actual)
Last update posted
Feb 25, 2013

2005 – 2008

United States locations

U.S. sites
46
U.S. states
26
U.S. cities
41
Facility City State ZIP Site status
Not listed Mobile Alabama 36617 —
Not listed Laguna Hills California 92653 —
Not listed Los Angeles California 90033 —
Not listed Orange California 92868 —
Not listed Palm Springs California 92262 —
Not listed San Diego California 92134 —
Not listed Torrance California 90509 —
Not listed Denver Colorado 80204 —
Not listed Denver Colorado 80262 —
Not listed Hartford Connecticut 06102 —
Not listed Newark Delaware 19718 —
Not listed Washington D.C. District of Columbia 20037 —
Not listed Miami Florida 33136 —
Not listed Atlanta Georgia 30342 —
Not listed Honolulu Hawaii 96813 —
Not listed Chicago Illinois 60612 —
Not listed Indianapolis Indiana 46202 —
Not listed Indianapolis Indiana 46280 —
Not listed Boston Massachusetts 02118 —
Not listed Springfield Massachusetts 01199 —
Not listed West Roxbury Massachusetts 02132 —
Not listed Detroit Michigan 48201 —
Not listed Grand Rapids Michigan 49506 —
Not listed Minneapolis Minnesota 55422 —
Not listed St Louis Missouri 63110 —
Not listed St Louis Missouri 63131 —
Not listed Butte Montana 59701 —
Not listed Lincoln Nebraska 68510 —
Not listed Laconia New Hampshire 03246 —
Not listed Buffalo New York 14215 —
Not listed Bismarck North Dakota 58501 —
Not listed Fargo North Dakota 58122 —
Not listed Cleveland Ohio 44109 —
Not listed Columbus Ohio 43210 —
Not listed Columbus Ohio 43215 —
Not listed Toledo Ohio 43608 —
Not listed Zanesville Ohio 43701 —
Not listed Pittsburgh Pennsylvania 15261 —
Not listed Corsiana Texas 75151 —
Not listed Fort Worth Texas 76135 —
Not listed Houston Texas 77026 —
Not listed Houston Texas 77030 —
Not listed Salt Lake City Utah 84102 —
Not listed Charlottesville Virginia 22906 —
Not listed Madison Wisconsin 53792 —
Not listed Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00195351, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 25, 2013 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00195351 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →